Michele D’ Amico - Concepedia

Author

Michele D’ Amico

University of Campania "Luigi Vanvitelli"

Also Known As

M AMICO, M Amico, M. Amico, Maria Denise Amico, Michele D' Amico, Michele D' Amico, Michele D. Amico, Michele D.’ Amico, Michele D´Amico, Michele D’ Amico

Publications

427

Citations

H-Index

Concepts

All Affiliations

University of Campania "Luigi Vanvitelli"University of Molise Ospedale dei Pellegrini Saint Camillus International University of Health and Medical Sciences Federico II University Hospital

About

Michele D’ Amico is an author at University of Campania "Luigi Vanvitelli" specializing in medicine, cardiovascular pharmacology, and atrial fibrillation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	84
2	Health Sciences	2	2	34
3	Public Health	2	2	50
4	Diabetes	1	1	23
5	Immunology	1	1	11

Michele D’ Amico

Publications

358

Citations

H-Index

Page 1

	Year	Citations
SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis Celestino Sardu, Maria Consiglia Trotta, Ferdinando Carlo Sasso, Cardiovascular Diabetology	2023	99
Lipocortin 1 reduces myocardial ischemia‐reperfusion injury by affecting local leukocyte recruitment Michele D’ Amico, Clara Di Filippo, Mylinh La, The FASEB Journal	2000	98
ARPE-19-derived VEGF-containing exosomes promote neovascularization in HUVEC: the role of the melanocortin receptor 5 Rosa Maisto, María Rosa Oltra, Lorena Vidal‐Gil, Cell Cycle	2019	41
Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study Celestino Sardu, Gaetano Santulli, Germano Guerra, Journal of Clinical Medicine Epicardial Thoracoscopic AblationCardiac AnaesthesiaCardiovascular Translational ResearchCardiovascular DiseaseMyocardial Infarction	2020	39
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside Celestino Sardu, Massimo Massetti, Lucia Scisciola, Pharmacological Research	2022	36
MicroRNAs modulation and clinical outcomes at 1 year of follow-up in obese patients with pre-diabetes treated with metformin vs. placebo Celestino Sardu, Maria Consiglia Trotta, Gorizio Pieretti, Acta Diabetologica ObesityMetabolic SyndromeMicrornas ModulationDiabetes ManagementDiabetes	2021	23
Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study Celestino Sardu, Gaetano Santulli, Germano Guerra, Preprints.org Epicardial Thoracoscopic AblationCardiac AnaesthesiaCardiovascular Translational ResearchCardiovascular DiseaseMyocardial Infarction	2020	11
Serum Levels of Cortisol, Immunoglobulin, and C-reactive Protein in Burn Patients. D Pileri, A. Accardo-Palumbo, L D'Amelio, PubMed Severe SepsisImmunologyImmune RegulationThermal TherapyDermatology	2009	11

Page 1